Research subject group : patients aged 14 years and above presenting in a community pharmacy for a newly prescribed medicine for asthma/chronic obstructive pulmonary disease ( COPD ) ; hypertension ; type 2 diabetes or anticoagulant/antiplatelet agents in two geographical regions in England .